Overview

In this webinar we will go through the thought process and challenges associated with implementation of Sustainability into medicinal product life cycle, from drug development to commercial.

Speaker

Ester Lovsin Barle, Global Head, Product Sustainability and Stewardship, Takeda Pharmaceuticals

Ester Lovsin Barle, DVM, MSc, PhD, MScTox is the Global Head of Product Sustainability and Stewardship at Takeda Pharmaceuticals. She lives in Zurich, Switzerland.

Ester is passionate about generating value with product safety and sustainability. She is leading cross-organizational product sustainability workstream Sustainability by Design for the Planet pillar of purpose led sustainability in Takeda. Her responsibilities also include product stewardship topics, such as Safety Data Sheet process, maintaining article and material regulatory compliance and scientific development and cross-organizational implementation of health based exposure limits (HBEL) in support of research and manufacturing in Takeda globally. Previously she has held corporate positions at Lonza and Novartis. She has been working in pharmaceutical industry for over 15 years. She received her PhD in veterinary sciences from University of Ljubljana, Slovenia and a second masters degree in toxicology and risk assessment from Medical University in Vienna. Ester is a certified toxicologist.

The material presented in this webinar has not been peer-reviewed. Any opinions are the presenter's own and do not necessarily represent those of IChemE or the Pharma Special Interest Group. The information is given in good faith but without any liability on the part of IChemE.

Time

13:00–14:00 BST. 

Software

The presentation will be delivered via Microsoft Teams. We recommend downloading the app from the Microsoft website, rather than using the web portal.

You are advised to join the webinar at least ten minutes before the scheduled start time, to allow for your computer to connect.

Webinar archive

This webinar is free of charge and open to all to attend, but if you wish to access the slides and a recording to replay on demand then you will need to be a member of the Pharma Special Interest Group.